Canadian public insurance plans and delays in patient access to innovative medicines

Canadians relying on public insurance plans face significant delays accessing new medicines. This graph breaks down the sequential approval and listing process, and demonstrates how long it takes Canadians to access innovative medicines.


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.